Regado Biosciences, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Regado Biosciences, Inc. | RGDO - |
Last trade $8.87 |
$4.00 |
$0.00 | 5.2 million | 4/11/2014 |
Jefferies, Deutsche Bank Securities, Cowen & Co. |
Co-Manager(s): |
|
Filing(s): Filed 2013-04-29
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Regado Biosciences, Inc., and our comprehensive analysis, click "Buy Market Research".
Regado Biosciences, Inc. Quote & Chart - Click for current quote -
RGDO
About Regado Biosciences, Inc. (adapted from Regado Biosciences, Inc. prospectus):
They are a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "RGDO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved